Delivery Order 36F79719D0160-36C24524N0196
Award Date 12/6/23
Potential Completion Date 12/8/23
Potential Value $17K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bartlett, TN 38134, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $15,646 delivery order to Catalyst Pharmaceuticals, Inc. for AMIFAMPRIDINE (FIRDAPSE) 10MG pharmaceutical products. The firm fixed price order was placed against Catalyst Pharmaceuticals' GSA Schedule contract for Pharmaceuticals and Drugs, with performance taking place in Bartlett, Tennessee. No set-aside designation was applied to this order to fulfill VHA medication needs as...
- This federal contract award to Catalyst Pharmaceuticals, Inc., doing business as Catalyst Pharmaceuticals, is for the delivery of the pharmaceutical product AMIFAMPRIDINE (FIRDAPSE) 10MG. The contract, valued at $18,526.09, was awarded by the Department of Veterans Affairs (VA) and its Veterans Health Administration (VHA) network. It is a firm fixed-price delivery order placed against Catalyst's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract. The contract has no set-aside...
- Catalyst Pharmaceuticals, Inc. was awarded a delivery order valued at $18,978.13 by Veterans Integrated Service Network 5 (VISN 5), a civilian agency within the Department of Veterans Affairs, for the supply of Firdapse 10 mg tablets. This contract, effective December 17, 2025, with an ultimate completion date of December 19, 2025, operates under a firm fixed-price model and carries no set-aside designation. The award is placed against the Pharmaceuticals and Drugs Federal Supply Schedule...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $15,080.48 delivery order to Catalyst Pharmaceuticals, Inc. for FIRDAPSE 10MG. The order was placed against the Pharmaceuticals and Drugs Federal Supply Schedule contract (FSS-61-IB), with a firm fixed price and place of performance in Miami, Florida. No set-aside designation was used for this award to the prime contractor Catalyst Pharmaceuticals for the branded drug to support...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 awarded a $154,859.62 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule to Catalyst Pharmaceuticals, Inc. for the provision of 10mg Firdapse (amifampridine) tablets. The order is for a firm fixed price and has a period of performance through October 31, 2022. The Pharmaceuticals and Drugs schedule, managed by GSA, provides government agencies access to...
- This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) to Catalyst Pharmaceuticals, Inc., a for-profit pharmaceutical company specializing in rare disease therapies. The contract is for the supply of FIRDAPSE 10 MG, an FDA-approved treatment for Lambert-Eaton myasthenic syndrome, a rare autoimmune disorder. The contract has a ceiling value of $18,978.13 and an ultimate completion date of September 29, 2025. The contract is not set-aside and is placed against...
- This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs Veterans Health Administration to Anovorx Distribution LLC, a small business for-profit limited liability company, to provide the medication Firdapse (Amifampridine). The contract has a potential value of $151,359.02 and a completion date of September 19, 2019. Anovorx Distribution LLC has provided various specialty pharmaceutical products to the VA and Department of the Army Medical Command...
- This is a firm fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Acorda Therapeutics, Inc., a biotechnology company specializing in neurological treatments. The contract, valued at $1,436,580.00, is for the supply of Dalfampridine 10mg tablets, a medication used to treat neurological disorders. The contract was awarded under Acorda's existing Federal Supply Schedule (FSS) contract with the VA, FSS-61-IB Pharmaceuticals and Drugs, which has a total ceiling...
- This federal contract award is a firm fixed-price delivery order issued by the U.S. Department of Veterans Affairs (VA) to Acorda Therapeutics, Inc., a biotechnology company that specializes in developing and commercializing therapies for neurological disorders. The contract, valued at $485,835.00, is for the supply of DALFAMPRIDINE 100 MG, a medication used to treat Parkinson's disease and multiple sclerosis symptoms. The contract was awarded on January 17, 2017, with a final completion date of...
- This is a federal contract award from the U.S. Department of Veterans Affairs (VA) to Acorda Therapeutics, Inc., a biotechnology company specializing in neurological disorder treatments. The contract is a Delivery Order against Acorda's existing Federal Supply Schedule (FSS) contract with the VA, valued at over $16.3 million and expiring in September 2024. This specific award, valued at $861,948.00, is for the supply of DALFAMPRIDINE, a medication used to treat Parkinson's disease symptoms....